L. casei CCFM419 had a potential ability to ameliorate insulin resistance and hyperglycemia in T2DM mice through underlying PI3K/Akt signaling pathway and gut flora-SCFAs-inflammation/GLP-1 mechanism (105, 106). This evidence concerns the gene AKT1 and Hyperglycemia.